BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 19, 2017
View Archived Issues
AntriaBio selects lead oral plasma kallikrein inhibitor candidates
Read More
InMed reports preclinical results in development of INM-405 for pain
Read More
OncBioMune Pharmaceuticals preparing clinical testing of OvcaVax
Read More
Lilly and CureVac enter global immune-oncology collaboration to develop mRNA cancer vaccines
Read More
Synspira commences phase Ia study of lead candidate for cystic fibrosis
Read More
Novartis starts phase I study of NMDA receptor NAM triggering milestone payment to Cadent
Read More
NexImmune, The Leukemia & Lymphoma Society to develop immunotherapy for AML
Read More
AST-2818 demonstrates antitumoral activity against EGFR T790M mutant NSCLC
Read More
Johnson & Johnson reviews highlights of third quarter 2017
Read More
Herpes vaccine HSV-529 safe and immunogenic in phase I trial
Read More
FDA gives fast track status to Radius Health's elacestrant
Read More
AbbVie and Harpoon Therapeutics enter immuno-oncology research collaboration
Read More
Mitsubishi Tanabe Pharma's acquisition of NeuroDerm complete
Read More
EMA grants orphan drug designation to Conatus' IDN-7314 for primary sclerosing cholangitis
Read More
Otsuka submits NDA for nalmefene in Japan
Read More
FDA advisory committee recommends approval of once-weekly semaglutide for type 2 diabetes
Read More
First-in-human phase I results presented for JNJ-64041757 immunotherapy in lung cancer
Read More
Astellas announces a new collaborative research agreement with TB Alliance
Read More
FDA approves CAR T therapy Yescarta for adults with relapsed or refractory large B-cell lymphoma
Read More
Sage Therapeutics describes novel NMDA receptor modulators
Read More
New glucosylceramidase activators identified at Lysosomal Therapeutics
Read More
FDA grants priority review to sNDA for Lynparza
Read More
AstraZeneca synthesizes novel serine-protein kinase ATM inhibitors
Read More
FluGen receives a grant from DOD to test universal flu vaccine against mismatched strains
Read More
University of Texas, Immune Sensor divulge new cyclic GMP-AMP synthase inhibitors
Read More
Loxo Oncology reports results from committee assessment of larotrectinib dataset
Read More
Protalix Biotherapeutics licenses PRX-102 to Chiesi outside U.S.
Read More
Vir Biotechnology collaborates with Alnylam and Visterra to develop programs for infectious diseases
Read More
Phase II luminespib study in non-small cell lung cancer meets primary endpoint
Read More
CEBPA gene novel mutation found to cause congenital lipodystrophy
Read More
